BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33277589)

  • 1. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
    Sheng KL; Kang L; Pridham KJ; Dunkenberger LE; Sheng Z; Varghese RT
    Sci Rep; 2020 Dec; 10(1):21246. PubMed ID: 33277589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
    Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
    BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
    Xiong Y; Feng Y; Qiao T; Han Y
    Cancer Biomark; 2020; 27(2):243-250. PubMed ID: 32083573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer.
    Herreros-Pomares A; de-Maya-Girones JD; Calabuig-Fariñas S; Lucas R; Martínez A; Pardo-Sánchez JM; Alonso S; Blasco A; Guijarro R; Martorell M; Escorihuela E; Chiara MD; Duréndez E; Gandía C; Forteza J; Sirera R; Jantus-Lewintre E; Farràs R; Camps C
    Cell Death Dis; 2019 Sep; 10(9):660. PubMed ID: 31506430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
    Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
    Li L; Wei Y; To C; Zhu CQ; Tong J; Pham NA; Taylor P; Ignatchenko V; Ignatchenko A; Zhang W; Wang D; Yanagawa N; Li M; Pintilie M; Liu G; Muthuswamy L; Shepherd FA; Tsao MS; Kislinger T; Moran MF
    Nat Commun; 2014 Nov; 5():5469. PubMed ID: 25429762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
    Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
    BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
    Xie H; Xie C
    Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.
    Arrieta O; Aviles-Salas A; Orozco-Morales M; Hernández-Pedro N; Cardona AF; Cabrera-Miranda L; Barrios-Bernal P; Soca-Chafre G; Cruz-Rico G; Peña-Torres ML; Moncada-Claudio G; Ramirez-Tirado LA
    Cancer Med; 2020 Apr; 9(7):2390-2402. PubMed ID: 32043750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic 4-gene expression signature for squamous cell lung carcinoma.
    Li J; Wang J; Chen Y; Yang L; Chen S
    J Cell Physiol; 2017 Dec; 232(12):3702-3713. PubMed ID: 28160492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
    Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy as second-line treatment and beyond for non-small cell lung cancer in a single center of China: Outcomes, toxicities, and clinical predictive factors from a real-world retrospective analysis.
    Chen M; Li Q; Xu Y; Zhao J; Zhang L; Wei L; Zhong W; Wang M
    Thorac Cancer; 2020 Jul; 11(7):1955-1962. PubMed ID: 32468726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.
    Yi M; Li T; Qin S; Yu S; Chu Q; Li A; Wu K
    Biomed Res Int; 2020; 2020():4169691. PubMed ID: 32149105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.